Knowledge, practice and acceptability of HPV vaccine by mothers of adolescent girls in Ilorin, Nigeria
Authors:
- Kikelomo T. AdesinaKAKikelomo T. Adesina
- Aishat SakaASAishat Saka
- Salamat A. Isiaka- LawalSLSalamat A. Isiaka- Lawal
- Omotayo O. AdesiyunOAOmotayo O. Adesiyun
- A. GobirAGA. Gobir
- Adebunmi.O. OlarinoyeAOAdebunmi.O. Olarinoye
- Grace G. EzeokeGEGrace G. Ezeoke
Open Access
- 14 March 2018
- journal article
- research article
- Published by Knowledge E DMCC in Sudan Journal of Medical Sciences
- Vol. 13 (1) , 33-49
Abstract
Background: Human Papilloma Virus (HPV) is a sexually transmitted cause of carcinoma of the cervix. An important determinant of the success of a primary preventive strategy like HPV vaccination is the knowledge and willingness of parents to vaccinate adolescents before sexual debut. Materials and methods of study: A cross sectional descriptive survey of mothers of girls in 8 secondary schools in Ilorin was carried out from February to April 2015. Schools were selected using multi staged sampling. Descriptive and inferential statistics were performed with Chi Square and ANOVA. Results: There were 470 questionnaires returned for analysis out of 600, giving a response rate of 78.3%. One hundred and sixty-one (34.3%) knew HPV to be sexually transmitted infection and 40.4% knew it was the cause of cervical cancer. While 35.1% were aware of HPV vaccine, only 1.9% had ever vaccinated their children.Less than half (44.9%) were willing to vaccinate their children. Women with good knowledge of HPV and cervical cancer were more willing to vaccinate their children than women with poor knowledge (P <0.001). Conclusion: There is poor knowledge of HPV and practice of vaccination among mothers in llorin. Willingness of mothers to vaccinate their daughters is suboptimal. Mother’s knowledge is an important determinant of HPV vaccination of adolescents.Keywords
This publication has 16 references indexed in Scilit:
- Knowledge and Awareness of HPV Vaccine and Acceptability to Vaccinate in Sub-Saharan Africa: A Systematic ReviewPLOS ONE, 2014
- Barriers to Human Papillomavirus Vaccine Acceptability in IsraelVaccine, 2013
- Awareness, Acceptability and Uptake of Human Papilloma Virus Vaccine Among Cameroonian School-Attending Female AdolescentsJournal of Community Health, 2012
- Assessing the Effectiveness of a Community-Based Sensitization Strategy in Creating Awareness About HPV, Cervical Cancer and HPV Vaccine Among Parents in North West CameroonJournal of Community Health, 2012
- HPV vaccine acceptability in Ghana, West AfricaVaccine, 2011
- Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South AfricaVaccine, 2010
- HPV vaccine acceptability among Kenyan womenVaccine, 2010
- Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trialThe Lancet, 2007
- Chapter 2: The burden of HPV-related cancersVaccine, 2006
- Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 VaccineJNCI: Journal of the National Cancer Institute, 2004